Document Detail

Novel Therapeutic Approach for Neurodegenerative Pathologies: Multitarget Iron-Chelating Drugs Regulating Hypoxia-Inducible Factor 1 Signal Transduction Pathway.
MedLine Citation:
PMID:  22156453     Owner:  NLM     Status:  Publisher    
Our novel multimodal brain-permeable iron-chelating compounds M30 and HLA20 were demonstrated to possess neuroprotective/neurorescue activities in vitro and in vivo against several insults applicable to various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Neuroprotection by iron chelators has been widely recognized with respect to their ability to prevent reactive oxygen species generation in the Fenton reaction by sequestering redox-active iron. An additional neuroprotective mechanism of iron-chelating compounds is associated with their ability to regulate the transcriptional activator hypoxia-inducible factor 1 (HIF-1). HIF-1 is a 'master switch' being an important physiological response mechanism, likely enhancing neuroprotective compensatory pathways involved in many physiological processes within the brain. This mini-review will discuss the multifunctional mechanisms of action of the drugs, M30 and HLA20 in preclinical models of neurodegeneration with a specific emphasis on their ability to activate the HIF-1 signal transduction pathway.
Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Related Documents :
1730293 - Arachidonic acid induces phosphorylation of an 18 kda protein in electrically permeabil...
1667763 - Inhibition of protein kinase c activity in cultured pituitary cells attenuates both cyc...
18548093 - The dual pi3 kinase/mtor inhibitor pi-103 prevents p53 induction by mdm2 inhibition but...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-09
Journal Detail:
Title:  Neuro-degenerative diseases     Volume:  -     ISSN:  1660-2862     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101189034     Medline TA:  Neurodegener Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 S. Karger AG, Basel.
Eve Topf Centers of Excellence for Neurodegenerative Diseases Research and Department of Molecular Pharmacology, Rappaport Family Research Institute, Technion Faculty of Medicine, Haifa, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancie...
Next Document:  Food Prehension and Manipulation in Microcebus murinus (Prosimii, Cheirogaleidae).